Literature DB >> 773828

Antigenicity of converting phages obtained from Clostridium botulinum types C and D.

K Oguma, H Iida, M Shiozaki, K Inoue.   

Abstract

Phage conversion of toxigenicity in Clostridium botulinum types C and D was accomplished by using nontoxigenic strains and phages purified from plaques. Although the morphology of the converting phages seemed to be the same, they were divided into three groups on the basis of their conversion spectrum. The first group consists of phages obtained from toxogenic strains C-Stockholm and C-468. The second group consists of phages from strains D-1873 and C-203. The third group consists of phages from strains D-South African and D-4947. These converting phages were also classified into the same three groups by a neutralization test with specific antiphage sera. Cross-neutralization, however, was observed between phages belonging to group 1 and group 2,by both the neutralization test of converting ability and by a plaque experiment in which the surviving rates of phages were calculated after treatment with each antiphage serum. The antigenic differences among these converting phages should probably comprise one of the reasons for the existence of the specific infection spectrum in C. botulinum types C and D.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 773828      PMCID: PMC420688          DOI: 10.1128/iai.13.3.855-860.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  The stability of toxigenicity in Clostridium botulinum types C and D.

Authors:  K Oguma
Journal:  J Gen Microbiol       Date:  1976-01

2.  Genetic factors in Corynebacterium diphtheriae conversion.

Authors:  N B GROMAN; M EATON
Journal:  J Bacteriol       Date:  1955-12       Impact factor: 3.490

3.  Bacteriophage and toxigenicity in Clostridium botulinum: an additional evidence for phage conversion.

Authors:  K Oguma; H Iida; K Inoue
Journal:  Jpn J Microbiol       Date:  1973-09

4.  Bacteriophage and the toxigenicity of Clostridium botulinum type D.

Authors:  M W Eklund; F T Poysky; S M Reed
Journal:  Nat New Biol       Date:  1972-01-05

5.  Phage-conversion of toxigenicity in Clostridium botulinum types C and D.

Authors:  K Inoue; H Iida
Journal:  Jpn J Med Sci Biol       Date:  1971-02

6.  Conversion of toxigenicity in Clostridium botulinum type C.

Authors:  K Inoue; H Iida
Journal:  Jpn J Microbiol       Date:  1970-01

7.  Bacteriophages of Clostridium botulinum.

Authors:  K Inoue; H Iida
Journal:  J Virol       Date:  1968-05       Impact factor: 5.103

8.  Observations on nonconverting phage, c-n71, obtained from a nontoxigenic strain of Clostridium botulinum type C.

Authors:  K Oguma; H Iida; K Inoue
Journal:  Jpn J Microbiol       Date:  1975-06

9.  Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.

Authors:  M W Eklund; F T Poysky
Journal:  Appl Microbiol       Date:  1974-01

10.  Bacteriophage and the toxigenicity of Clostridium botulinum type C.

Authors:  M W Eklund; F T Poysky; S M Reed; C A Smith
Journal:  Science       Date:  1971-04-30       Impact factor: 47.728

View more
  14 in total

1.  Cloning and complete nucleotide sequence of the gene for the main component of hemagglutinin produced by Clostridium botulinum type C.

Authors:  K Tsuzuki; K Kimura; N Fujii; N Yokosawa; T Indoh; T Murakami; K Oguma
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

2.  The genome sequence of Clostridium botulinum type C neurotoxin-converting phage and the molecular mechanisms of unstable lysogeny.

Authors:  Yoshihiko Sakaguchi; Tetsuya Hayashi; Ken Kurokawa; Keisuke Nakayama; Kenshiro Oshima; Yukako Fujinaga; Makoto Ohnishi; Eiichi Ohtsubo; Masahira Hattori; Keiji Oguma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-15       Impact factor: 11.205

3.  Cloning of the structural gene for Clostridium botulinum type C1 toxin and whole nucleotide sequence of its light chain component.

Authors:  K Kimura; N Fujii; K Tsuzuki; T Murakami; T Indoh; N Yokosawa; K Oguma
Journal:  Appl Environ Microbiol       Date:  1991-04       Impact factor: 4.792

4.  Two different types of ADP-ribosyltransferase C3 from Clostridium botulinum type D lysogenized organisms.

Authors:  K Moriishi; B Syuto; M Saito; K Oguma; N Fujii; N Abe; M Naiki
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

5.  Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies.

Authors:  K Oguma; S Murayama; B Syuto; H Iida; S Kubo
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

6.  Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum.

Authors:  K Oguma; T Agui; B Syuto; K Kimura; H Iida; S Kubo
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

Review 7.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

8.  Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.

Authors:  K Oguma; B Syuto; H Iida; S Kubo
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

9.  Phage conversion to hemagglutinin production in Clostridium botulinum types C and D.

Authors:  K Oguma; H Iida; M Shiozaki
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

10.  Characterization of bacteriophage nucleic acids obtained from Clostridium botulinum types C and D.

Authors:  N Fujii; K Oguma; N Yokosawa; K Kimura; K Tsuzuki
Journal:  Appl Environ Microbiol       Date:  1988-01       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.